Mental Health Clinical Trials: Current Dynamics And Pipeline Outlook

Table of Contents

Chapter 1. Research Methodology
                   1.1. Report Scope
                   1.2. List of Secondary Sources
                   1.3. List of Abbreviations
Chapter 2. Executive Summary
                   2.1. Mental Health Clinical Trials Landscape Overview
                   2.2. Market Dynamics
                   2.3. Prevalence Trends Analysis
                       2.3.1. Anxiety Disorders
                       2.3.2. Depression
                       2.3.3. Bipolar affective disorder
                       2.3.4. Dissociation and dissociative disorders
                       2.3.5. Schizophrenia
                       2.3.6. Others
                   2.4. R&D Investment & Funding Analysis
                   2.5. Industry Ecosystem Analysis
                   2.6. Regulatory Framework
                   2.7. List of Top 100 Active Trials by Phase, Sponsor, and Indication
                   2.8. Emerging Clinical Trial Model Analysis
Chapter 3. Global Mental Health Clinical Trials, by Phase
                   3.1. Phase I
                   3.2. Phase II
                   3.3. Phase III
                   3.4. Phase IV
Chapter 4. Global Mental Health Clinical Trials, by Study Design
                   4.1. Interventional Trials
                   4.2. Observational Studies
                   4.3. Expanded Access
Chapter 5. Global Mental Health Clinical Trials, by Key Indications
                   5.1. Anxiety Disorders
                   5.2. Depression
                   5.3. Bipolar affective disorder
                   5.4. Dissociation and dissociative disorders
                   5.5. Schizophrenia
                   5.6. Others
Chapter 6. Global Mental Health Clinical Trials, by Region
                   6.1. North America
                   6.2. Europe
                   6.3. Asia Pacific
                   6.4. Latin America
                   6.5. Middle East & Africa